Compare · head to head
Astrana Health vs GeneDx
Astrana Health ranks higher overall — 360 rank 62 vs 6.
Astrana Health leads on Value (53 vs 35), Quality (44 vs 28) and Growth (73 vs 24). GeneDx leads on Safety (42 vs 35). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Providers & Services | Health Care Providers & Services |
| Size | Medium | Medium |
| ISIN | US03763A2078 | US81663L2007 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 62 | 6 |
| Value | 53 | 35 |
| Quality | 44 | 28 |
| Growth | 73 | 24 |
| Safety | 35 | 42 |
| Sentiment | 56 | 59 |
| Quality details | ||
| Profitability | 44 | 26 |
| Cash Truth | 44 | 30 |
Astrana Health vs Privia HealthAstrana Health vs ChemedAstrana Health vs Quest DiagnosticsAstrana Health vs DaVitaAdd a third stock →
Full analyses: Astrana Health · GeneDx
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100